[Surgery of primary hyperparathyroidism. Contribution of the peroperative assay of urinary cyclic AMP]. 1987

P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
Clinique chirurgicale, Hôpital Cochin, Paris.

The increase of nephrogenic cyclic AMP is an excellent index of parathyroid hypersecretion. A successful treatment of primary hyperparathyroidism results in a rapid fall in nephrogenic cAMP. In a series of 24 patients with proven primary hyperparathyroidism (hyperplasia 3, adenoma 21) and 2 patients with suspected hyperparathyroidism, the success of surgical excision was evaluated by measuring the urinary cAMP/urinary creatinine ratio (R), which in the absence of renal impairment, is proportional to the level of nephrogenic cAMP. Sequential assays of urinary cAMP and creatinine were performed during surgery; laboratory results were available within less than one hour. Among 22 patients with elevated baseline value or R, R became normal in 18 and decreased by more than 50% in 3; these findings suggested that the operation would be successful. In 1 case, R was not measured as the patient had impaired renal function. In another patient with normal baseline value of R, R did not significantly decrease after excision. Surgery failed in 1 patient, although the high value of R at the end of the operation should have prompted us to continue. Finally, in 2 patients the diagnosis was erroneous since R was lower than 0.5 as in controls. Surgeons, therefore, now have a reliable biochemical method at their disposal, but its use will be limited by its cost and complexity.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007432 Intraoperative Period The period during a surgical operation. Intraoperative Periods,Period, Intraoperative,Periods, Intraoperative
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
April 1981, The New England journal of medicine,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
October 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
February 1975, Australian and New Zealand journal of medicine,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
December 1980, The New England journal of medicine,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
May 1993, Annals of surgery,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
January 1975, Annales de medecine interne,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
April 1977, American journal of surgery,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
January 1978, Scandinavian journal of urology and nephrology,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
October 1976, Archives of internal medicine,
P Icard, and Y Fulla, and P Bonnichon, and G Sarfati, and J Ingrand, and P Olszowy, and Y Chapuis
June 1979, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!